Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
IDYA compared with PRAX: revenue, margins and what each company keeps, and the suppliers and customers both name
IDYA
IDEAYA Biosciences, Inc.
Change
Mkt cap
Revenue
Revenue
PRAX
Praxis Precision Medicines, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
IDYA
IDEAYA Biosciences, Inc.
vs
PRAX
Praxis Precision Medicines, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
IDYA: latest quarter is a loss; flow not drawable. PRAX: latest quarter is a loss; flow not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
IDYA, solid
PRAX, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only IDYA
5
GILD
Gilead
supplier
PFE
Pfizer
supplier
—
Biocytogen
unlisted
supplier
—
Les Laboratoires Servier
unlisted
customer
1 more · IDYA chain
›
Shared
0
No shared counterparties.
Only PRAX
4
IONS
Ionis Pharmaceuticals
supplier
—
RogCon
unlisted
supplier
—
UCB Biopharma SRL
unlisted
customer
—
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Tenacia Biotechnology (Shanghai)
unlisted
customer
IDYA
IDEAYA Biosciences, Inc.
Change
31.95
▼
−2.86%
· post 31.95
Mkt cap
$3.1B
Revenue
$9M
Q2 FY26
Revenue
—
PRAX
Praxis Precision Medicines, Inc.
Change
285.69
▼
−1.02%
· post 289.04
Closed
Oct 30 '26
Mkt cap
$8.0B
Revenue
$7M
Q4 FY24
Revenue
$9M
FY24
vs
Compare
Closed
Oct 30 '26
IDYA
IDEAYA Biosciences, Inc.
vs
PRAX
Praxis Precision Medicines, Inc.
31.95
▼
−2.86%
post 31.95
Price
285.69
▼
−1.02%
post 289.04
$3.1B
Mkt cap
$8.0B
Q2 FY26
$9M
Revenue
$7M
Q4 FY24
—
Revenue
$9M
FY24
Change
Change
IDYA
31.95
▼
−2.86%
vs
PRAX
285.69
▼
−1.02%
Closed
Oct 30 '26